“…Inhibition of -glucosidase may currently be used to reduce intestinal uptake of glucose and subsequently lower post-prandial hyperglycemia in type 2 diabetics (Umpierrez et al, 2017). Animal studies describing the antihypertensive (Onsa-ard et al, 2013;Yuan, Wang, & Zhou, 2012), antioxidant (Sangwong, Sumida, & Sutthikhum, 2016;Yuan et al, 2012), antidiabetic (Han, Lee, Lee, Suh, & Park, 2016;Jung et al, 2010), memory enhancement (Kang, Lee, Kang, & Kang, 2013) and hypocholesterolemic (Lapphanichayakool, Sutheerawattananonda, & Limpeanchob, 2017) properties of silk protein hydrolysates have been reported. However, it appears that, to date, BAPs and protein hydrolysates derived from edible insects (other than B. mori), having bioactive properties in vitro and in small animals, have not been extensively studied in comparison to silk protein-derived peptides (Xia et al, 2013).…”